Radiation-Free Fetal Heart Rate Monitor Market Report 2026

The radiation-free fetal heart rate monitor market size has grown strongly in recent years. It will grow from $1.48 billion in 2025 to $1.62 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to rising awareness regarding prenatal health monitoring, increasing prevalence of high-risk pregnancies, advancements in non-invasive diagnostic technologies, growing adoption of portable healthcare devices, expansion of maternal healthcare infrastructure.

The radiation-free fetal heart rate monitor market size is expected to see strong growth in the next few years. It will grow to $2.36 billion by 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing demand for remote pregnancy monitoring solutions, rising integration of AI-enabled fetal analysis systems, growing adoption of wearable healthcare technologies, expansion of telehealth services in maternal care, increasing investments in advanced prenatal diagnostic devices. Major trends in the forecast period include increasing adoption of non-invasive fetal monitoring technologies, growing demand for continuous real-time fetal health tracking, rising preference for portable and home-based monitoring devices, expansion of wireless wearable fetal monitoring solutions, increasing focus on early detection of fetal abnormalities.

The rising awareness of prenatal care is expected to propel the growth of the radiation free fetal heart rate monitor market going forward. Prenatal care refers to the regular medical and health checkups, guidance, and support provided to a pregnant woman to ensure the health and well-being of both mother and baby throughout pregnancy. Awareness of prenatal care is increasing due to public health campaigns that educate expectant mothers about the importance of early checkups, screenings, and healthy pregnancy practices to prevent complications and ensure the baby’s well-being. Awareness of prenatal care encourages expectant parents and healthcare providers to prioritize safe and regular monitoring of fetal health, which supports the adoption of radiation-free fetal heart rate monitors as a non-invasive, convenient, and reliable tool for tracking the baby’s well-being throughout pregnancy. For instance, in December 2024, the Office for Health Improvement & Disparities reported that the proportion of women attending their first antenatal appointment within 10 weeks of pregnancy increased to 63.5% in 2024. Therefore, the rising awareness of prenatal care is driving the growth of the radiation-free fetal heart rate monitor market.

The rising incidence of high risk pregnancies is expected to propel the growth of the radiation free fetal heart rate monitor market going forward. High risk pregnancies are pregnancies in which the mother or fetus has an elevated chance of complications or adverse outcomes compared with uncomplicated pregnancies. The incidence of high-risk pregnancies is increasing due to advanced maternal age, as older mothers are more likely to experience complications such as gestational diabetes, hypertension, and chromosomal abnormalities in the fetus. Radiation free fetal heart rate monitors support high risk pregnancies by enabling clinicians to continuously and safely monitor the fetal heartbeat and wellbeing throughout gestation, allowing early detection of complications without exposing the mother or fetus to harmful ionizing radiation. For instance, in June 2025, according to the report published by the National Center for Biotechnology Information (NCBI), a total of 20,005 fetal deaths at 20 weeks of gestation or later were reported in the United States in 2023, with an overall fetal mortality rate of 5.53 per 1,000 live births and fetal deaths, slightly higher than 5.48 in 2022, and the rate for deaths occurring at 20-27 weeks of gestation increasing by 4%, from 2.79 in 2022 to 2.89 in 2023, reflecting a 4% rise in this high-risk outcome. Therefore, the rising incidence of high-risk pregnancies is driving the growth of the radiation-free fetal heart rate monitor market.

The expansion of remote patient monitoring programs is expected to propel the growth of the radiation free fetal heart rate monitor market going forward. Remote patient monitoring programs are systems that allow healthcare providers to track patient health data and clinical metrics outside traditional clinical settings. The expansion of remote patient monitoring programs is increasing due to the rising demand for continuous, at-home healthcare monitoring that helps manage chronic conditions and reduces hospital visits. Remote patient monitoring programs help facilitate the use of radiation-free fetal heart rate monitors by enabling expectant mothers to safely and continuously track fetal heart activity from home, allowing healthcare providers to monitor prenatal health in real time without exposing patients or fetuses to radiation, ensuring timely interventions and enhanced maternal-fetal care. For instance, in June 2025, the University of Mississippi Medical Center expanded its maternal telehealth program by providing remote patient monitoring equipment and nurse care coordination to pregnant patients, enabling continuous tracking of blood pressure, glucose, and other vital indicators to improve prenatal care access across rural communities. Therefore, the expansion of remote patient monitoring programs is driving the growth of the radiation-free fetal heart rate monitor market.

Major companies operating in the radiation-free fetal heart rate monitor market are Koninklijke Philips N. V., GE HealthCare, Mindray Medical International Limited, Drägerwerk AG & Co. KGaA, Nihon Kohden Corporation, CooperSurgical Inc., CONTEC Medical Systems Co. Ltd., Beurer GmbH, Spacelabs Healthcare, Heal Force Co. Ltd., Edan Instruments Inc., EasyCare Medical Pvt. Ltd., Bionet Co. Ltd., B-Arm Medical Pvt. Ltd., Huntleigh Healthcare Ltd., HeraMED, InnAccel Technologies Pvt. Ltd., Accusure, Banglijian Medical, Babyfun, Promed Group, Paxmax, Wallach Surgical Devices.

North America was the largest region in the radiation-free fetal heart rate monitor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiation-free fetal heart rate monitor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the radiation-free fetal heart rate monitor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiation-free fetal heart rate monitor market consists of sales of fetal stress test systems, wireless patch‑based fetal monitors, and fetal phonocardiography (PCG) systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.